Literature DB >> 19679230

The evaluation of a user-friendly lateral flow assay for the serodiagnosis of human brucellosis in Kazakhstan.

Sulushash Mizanbayeva1, Henk L Smits, Katya Zhalilova, Theresia H Abdoel, Stanislaw Kozakov, Kenes S Ospanov, Philip H Elzer, James T Douglas.   

Abstract

Serum samples from all patients with culture-confirmed brucellosis including those with chronic disease from Kazakhstan tested positive in the serum agglutination test for titers > or = 1:25 and reacted in the Brucella immunoglobulin M/immunoglobulin G lateral flow assay (LFA) confirming the high sensitivity of these assays. The strong reactivity in the LFA observed for the majority (92.1%) of the samples from the patients with culture-confirmed brucellosis together with the user-friendliness of the assay procedure makes the LFA ideal for the confirmation of brucellosis in endemic areas in Kazakhstan. The Rose Bengal test lacked sensitivity in particular for patients with chronic brucellosis therefore limiting its value as a quick screening assay. The study emphasizes the importance of the LFA as a useful, rapid, and easy-to-perform tool in the diagnostic testing of brucellosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679230     DOI: 10.1016/j.diagmicrobio.2009.05.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  9 in total

Review 1.  Policies and Livestock Systems Driving Brucellosis Re-emergence in Kazakhstan.

Authors:  Wendy Beauvais; Richard Coker; Gulzhan Nurtazina; Javier Guitian
Journal:  Ecohealth       Date:  2015-04-30       Impact factor: 3.184

Review 2.  Brucellosis in low-income and middle-income countries.

Authors:  Matthew P Rubach; Jo E B Halliday; Sarah Cleaveland; John A Crump
Journal:  Curr Opin Infect Dis       Date:  2013-10       Impact factor: 4.915

3.  Analyzing the spatial and temporal distribution of human brucellosis in Azerbaijan (1995 - 2009) using spatial and spatio-temporal statistics.

Authors:  Rakif Abdullayev; Ian Kracalik; Rita Ismayilova; Narmin Ustun; Ayden Talibzade; Jason K Blackburn
Journal:  BMC Infect Dis       Date:  2012-08-08       Impact factor: 3.090

4.  The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease.

Authors:  Ramón Díaz; Aurora Casanova; Javier Ariza; Ignacio Moriyón
Journal:  PLoS Negl Trop Dis       Date:  2011-04-19

5.  Epidemiology of Brucellosis and Genetic Diversity of Brucella abortus in Kazakhstan.

Authors:  Elena Shevtsova; Alexandr Shevtsov; Kasim Mukanov; Maxim Filipenko; Dinara Kamalova; Igor Sytnik; Marat Syzdykov; Andrey Kuznetsov; Assel Akhmetova; Mira Zharova; Talgat Karibaev; Pavel Tarlykov; Erlan Ramanculov
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

6.  Poor performance of the rapid test for human brucellosis in health facilities in Kenya.

Authors:  William A de Glanville; Raquel Conde-Álvarez; Ignacio Moriyón; John Njeru; Ramón Díaz; Elizabeth A J Cook; Matilda Morin; Barend M de C Bronsvoort; Lian F Thomas; Samuel Kariuki; Eric M Fèvre
Journal:  PLoS Negl Trop Dis       Date:  2017-04-07

7.  Brucellosis in China: history, progress and challenge.

Authors:  Hai Jiang; David O'Callaghan; Jia-Bo Ding
Journal:  Infect Dis Poverty       Date:  2020-05-24       Impact factor: 4.520

8.  Comparative performance of lateral flow immunochromatography, iELISA and Rose Bengal tests for the diagnosis of cattle, sheep, goat and swine brucellosis.

Authors:  Amahyel M Gusi; Wilson J Bertu; M Jesús de Miguel; Lucía Dieste-Pérez; Henk L Smits; Reuben A Ocholi; José M Blasco; Ignacio Moriyón; Pilar M Muñoz
Journal:  PLoS Negl Trop Dis       Date:  2019-06-19

Review 9.  Bovine brucellosis - a comprehensive review.

Authors:  Sandip Kumar Khurana; Anju Sehrawat; Ruchi Tiwari; Minakshi Prasad; Baldev Gulati; Muhammad Zubair Shabbir; Rajesh Chhabra; Kumaragurubaran Karthik; Shailesh Kumar Patel; Mamta Pathak; Mohd Iqbal Yatoo; Vivek Kumar Gupta; Kuldeep Dhama; Ranjit Sah; Wanpen Chaicumpa
Journal:  Vet Q       Date:  2021-01-01       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.